Literature DB >> 2877128

Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

M J Martin, S B Hulley, W S Browner, L H Kuller, D Wentworth.   

Abstract

The risks associated with various levels of serum cholesterol were determined by analysis of 6-year mortality in 361,662 men aged 35-57. Above the 20th percentile for serum cholesterol (greater than 181 mg/dl, greater than 4.68 mmol/l), coronary heart disease (CHD) mortality increased progressively; the relative risk was large (3.8) in the men with cholesterol levels above the 85th percentile (greater than 253 mg/dl, greater than 6.54 mmol/l). When men below the 20th cholesterol percentile were used as the baseline risk group, half of all CHD deaths were associated with raised serum cholesterol concentrations; half of these excess deaths were in men with cholesterol levels above the 85th percentile. For both CHD and total mortality, serum cholesterol was similar to diastolic blood pressure in the shape of the risk curve and in the size of the high-risk group. This new evidence supports the policy of a moderate fat intake for the general population and intensive treatment for those at high risk. There is a striking analogy between serum cholesterol and blood pressure in the epidemiological basis for identifying a large segment of the population (10-15%) for intensive treatment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2877128     DOI: 10.1016/s0140-6736(86)90597-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  150 in total

1.  Knowledge of nutrition and coronary heart disease in Riyadh, Saudi Arabia.

Authors:  I A Bani; T J Hashim
Journal:  J Community Health       Date:  1999-12

2.  Measuring serum total cholesterol: do vascular surgeons know what they are doing?

Authors:  L D Wijesinghe; L Gamage; D C Berridge; D J Scott
Journal:  Ann R Coll Surg Engl       Date:  1999-01       Impact factor: 1.891

Review 3.  Vascular pleiotropy of statins: clinical evidence and biochemical mechanisms.

Authors:  A S Callahan
Journal:  Curr Atheroscler Rep       Date:  2003-01       Impact factor: 5.113

4.  Effect of statin therapy on total mortality. Trial in a more varied population.

Authors:  Abdullah Alkhenizan
Journal:  Can Fam Physician       Date:  2003-06       Impact factor: 3.275

Review 5.  Choosing quality of care measures based on the expected impact of improved care on health.

Authors:  A L Siu; E A McGlynn; H Morgenstern; M H Beers; D M Carlisle; E B Keeler; J Beloff; K Curtin; J Leaning; B C Perry
Journal:  Health Serv Res       Date:  1992-12       Impact factor: 3.402

6.  Guidelines on preventing cardiovascular disease in clinical practice.

Authors:  R Jackson
Journal:  BMJ       Date:  2000-03-11

Review 7.  Primary prevention of cardiovascular disease: managing hypertension and hyperlipidaemia.

Authors:  F D R Hobbs
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

8.  A prospective study of hyperlipidemia as a pathogenic factor in sudden hearing loss.

Authors:  D Ullrich; G Aurbach; C Drobik
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

9.  Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients.

Authors:  J C Mazurkiewicz; G F Watts; F G Warburton; B M Slavin; C Lowy; E Koukkou
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

10.  Coronary heart disease rates within a small urban area in Belgium.

Authors:  G de Backer; G Thys; I de Craene; Y Verhasselt; S de Henauw
Journal:  J Epidemiol Community Health       Date:  1994-08       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.